All Stories

  1. Self‐blood pressure monitoring as a tool to increase hypertension awareness, adherence to antihypertensive therapy, and blood pressure control
  2. Relationship of a Body Shape Index and Body Roundness Index with carotid atherosclerosis in arterial hypertension
  3. The Unsolved Conundrum of Optimal Blood Pressure Target During Acute Haemorrhagic Stroke: A Comprehensive Analysis
  4. The prognostic role of the cardio-ankle vascular index
  5. Para-perirenal distribution of body fat is associated with reduced glomerular filtration rate regardless of other indices of adiposity in hypertensive patients
  6. Renal effects of Takaysu arteritis
  7. Hyperuricemia and high blood pressure at rest and during exercise: Guilty or innocent? The jury is still out
  8. Retinal vascular imaging in cardiovascular medicine: New tools for an old examination
  9. Relationship between kidney findings and systemic vascular damage in elderly hypertensive patients without overt cardiovascular disease
  10. The relationships between lipid ratios and arterial stiffness
  11. Serum uric acid is not independently associated with plasma renin activity and plasma aldosterone in hypertensive adults
  12. [OP.3B.03] INFLUENCE OF SUBCLINICAL RENAL DAMAGE ON EARLY VASCULAR AGING IN PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS
  13. [OP.4B.03] CIRCULATING ALDOSTERONE LEVELS ARE ASSOCIATED WITH CONCENTRIC LEFT VENTRICULAR GEOMETRY IN ESSENTIAL HYPERTENSIVE PATIENTS
  14. [OP.7B.08] INFLUENCE OF GENDER ON THE RELATIONSHIPS BETWEEN NEW INDICES OF ADIPOSITY AND LEFT VENTRICULAR MASS AND HYPERTROPHY IN HYPERTENSIVE PATIENTS
  15. [PP.01.25] INTERNATIONAL REGISTRY FOR AMBULATORY BLOOD PRESSURE AND ARTERIAL STIFFNESS TELEMONITORING (VASOTENS REGISTRY)
  16. [PP.07.17] VITAMIN D RECEPTOR GENE POLYMORPHISMS, FGF-23 AND FETUIN-A IN ESSENTIAL HYPERTENSION
  17. [PP.22.07] RELATIONSHIPS OF SYMMETRICAL AND ASYMMETRICAL AMBULATORY ARTERIAL STIFFNESS INDEX (AASI) WITH PRECLINICAL RENAL DAMAGE IN UNTREATED HYPERTENSIVE PATIENTS
  18. Association between uric acid and renal function in hypertensive patients: which role for systemic vascular involvement?
  19. Vascular Health Assessment of The Hypertensive Patients (VASOTENS) Registry: Study Protocol of an International, Web-Based Telemonitoring Registry for Ambulatory Blood Pressure and Arterial Stiffness
  20. Reply
  21. Electrocardiography for Assessment of Hypertensive Heart Disease: A New Role for an Old Tool
  22. Association Between Uric Acid and Renal Hemodynamics: Pathophysiological Implications for Renal Damage in Hypertensive Patients
  23. Relationship between aortic root size and glomerular filtration rate in hypertensive patients
  24. Vascular health assessment of the hypertensive patients (Vasotens) registry: Rationale, design and methods of an international registry for ambulatory blood pressure and arterial stiffness telemonitoring
  25. Eva in Sle
  26. The renal resistive index: is it a misnomer?
  27. Average real variability of 24-h systolic blood pressure is associated with microalbuminuria in patients with primary hypertension
  28. 1D.04
  29. PP.04.22
  30. PP.10.06
  31. PP.17.24
  32. PP.22.05
  33. PP.41.03
  34. PP.42.06
  35. PP.42.07
  36. Relationship Between Short-Term Blood Pressure Variability and Subclinical Renal Damage in Essential Hypertensive Patients
  37. Renal haemodynamics and severity of carotid atherosclerosis in hypertensive patients with and without impaired renal function
  38. Plasma aldosterone and its relationship with left ventricular mass in hypertensive patients with early-stage chronic kidney disease
  39. Vitamin D receptor gene polymorphisms and plasma renin activity in essential hypertensive individuals
  40. Relationships between mild hyperuricaemia and aortic stiffness in untreated hypertensive patients
  41. Association of renal resistive index with aortic pulse wave velocity in hypertensive patients
  42. Metabolic syndrome in hypertensive patients: An unholy alliance
  43. Absence of an independent association between serum uric acid and left ventricular mass in Caucasian hypertensive women and men
  44. Subclinical atherosclerosis and fetuin-A plasma levels in essential hypertensive patients
  45. Inappropriately high left ventricular mass: marker of very high cardiovascular risk in patients with chronic kidney disease?
  46. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram
  47. Young woman with branchio-oto-renal syndrome and a novel mutation in the EYA-1 gene
  48. Left ventricular hypertrophy: not so much determinant of renal outcome?
  49. Renal Involvement in Psychological Eating Disorders
  50. Unfavourable interaction of microalbuminuria and mildly reduced creatinine clearance on aortic stiffness in essential hypertension
  51. Impact of type 2 diabetes on left ventricular geometry and diastolic function in hypertensive patients with chronic kidney disease
  52. Electrocardiography Plus Limited Echocardiography in Young, Newly Identified, Hypertensives: Some Considerations
  53. The progressive pathway of microalbuminuria: from early marker of renal damage to strong cardiovascular risk predictor
  54. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial)
  55. Resistin: A New Marker of Cardiorenal Risk?
  56. Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review
  57. Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function
  58. The Association of Microalbuminuria With Aortic Stiffness Is Independent of C-Reactive Protein in Essential Hypertension
  59. Clinical correlates of renal dysfunction in hypertensive patients without cardiovascular complications: the REDHY study
  60. Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease
  61. Influence of gender on the relation between the metabolic syndrome and left ventricular mass
  62. Impact of metabolic syndrome on left ventricular mass: Is the same in all ethnic groups and in men and women? Reply
  63. Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients
  64. Parathyroid hormone is inversely related to endothelin-1 in patients on haemodialysis
  65. Plasma Aldosterone and Its Relationships With Left Ventricular Mass in Essential Hypertensive Patients With the Metabolic Syndrome
  66. The metabolic syndromearterial stiffness relationship in patients with ischaemic stroke: role of inflammation
  67. Relationships between metabolic syndrome and left ventricular mass in hypertensive patients: does sex matter?
  68. Relationship of transforming growth factor-beta1with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transplantation
  69. Inverse Relationship Between Ambulatory Arterial Stiffness Index and Glomerular Filtration Rate in Arterial Hypertension
  70. The Metabolic Syndrome as a Prohypertensive State
  71. Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects
  72. Reply to: Is Increased Brachial Pulse Pressure a Reliable Predictor of Cardiovascular Risk in Old Hypertensive Subjects With Metabolic Syndrome?
  73. Circulating Levels of Adhesion Molecules in Chronic Kidney Disease Correlate with the Stage of Renal Disease and with C-Reactive Protein
  74. Metabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and function
  75. C-reactive protein and intercellular adhesion molecule-1 are stronger predictors of oxidant stress than blood pressure in established hypertension
  76. Impact of the Metabolic Syndrome on Total Arterial Compliance in Essential Hypertension Patients
  77. Relationship of Metabolic Syndrome With Pulse Pressure in Patients With Essential Hypertension
  78. Inflammation and endothelial activation are linked to renal function in long-term kidney transplantation
  79. Microalbuminuria and early endothelial activation in essential hypertension
  80. The Metabolic Syndrome and Its Relationship to Hypertensive Target Organ Damage
  81. Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients
  82. Influence of metabolic syndrome on hypertension-related target organ damage
  83. Usefulness of Microalbuminuria in Cardiovascular Risk Stratification of Essential Hypertensive Patients
  84. Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients
  85. Relationships between ambulatory white coat effect and left ventricular mass in arterial hypertension
  86. Pulsatile and steady 24-h blood pressure components as determinants of left ventricular mass in young and middle-aged essential hypertensives
  87. Insulin resistance and glomerular hemodynamics in essential hypertension
  88. Endothelium-derived factors in microalbuminuric and nonmicroalbuminuric essential hypertensives
  89. Changes of Plasma Endothelin and Growth Factor Levels, and of Left Ventricular Mass, After Chronic AT1-Receptor Blockade in Human Hypertension
  90. Insulin-like growth factor 1 and pressure load in hypertensive patients
  91. Insulin resistance and endogenous digoxin-like factor in obese hypertensive patients with glucose intolerance